105 related articles for article (PubMed ID: 2591947)
21. B- and T-lymphocytes in Hodgkin's disease. An immunohistochemical study utilizing heterologous and monoclonal antibodies.
Forni M; Hofman FM; Parker JW; Lukes RJ; Taylor CR
Cancer; 1985 Feb; 55(4):728-37. PubMed ID: 3155642
[TBL] [Abstract][Full Text] [Related]
22. Expression of human tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: a potential mechanism of immune evasion.
Ohshima K; Muta K; Nakashima M; Haraoka S; Tutiya T; Suzumiya J; Kawasaki C; Watanabe T; Kikuchi M
Int J Cancer; 2001 Jul; 93(1):91-6. PubMed ID: 11391627
[TBL] [Abstract][Full Text] [Related]
23. Phenotype of Hodgkin and Sternberg-Reed cells and expression of CD57 (LEU7) antigen.
Papadimitriou CS; Bai MK; Kotsianti AJ; Costopoulos JS; Hytiroglou P
Leuk Lymphoma; 1995 Dec; 20(1-2):125-30. PubMed ID: 8750633
[TBL] [Abstract][Full Text] [Related]
24. In situ quantification of T-cell subsets, NK-like cells and macrophages in Hodgkin's disease: quantity and quality of infiltration density depends on histopathological subtypes.
Gattringer G; Greil R; Radaszkiewicz T; Huber H
Blut; 1986 Jul; 53(1):49-58. PubMed ID: 3487362
[TBL] [Abstract][Full Text] [Related]
25. Nucleoli and AgNORs in Hodgkin's disease.
Mamaev NN; Medvedeva NV; Shust VF; Markochev AB; Pasternak ND
Mol Pathol; 1997 Jun; 50(3):149-52. PubMed ID: 9292150
[TBL] [Abstract][Full Text] [Related]
26. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma.
Timens W; Visser L; Poppema S
Lab Invest; 1986 Apr; 54(4):457-61. PubMed ID: 3083157
[TBL] [Abstract][Full Text] [Related]
27. Anti-Leu-3a antibody reactivity with Reed-Sternberg cells of Hodgkin's disease.
Oka K; Mori N; Kojima M
Arch Pathol Lab Med; 1988 Feb; 112(2):139-42. PubMed ID: 3257383
[TBL] [Abstract][Full Text] [Related]
28. Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia.
Hudnall SD; Betancourt E; Barnhart E; Patel J
Cytometry B Clin Cytom; 2008 Jan; 74(1):1-8. PubMed ID: 18061945
[TBL] [Abstract][Full Text] [Related]
29. Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain.
Stein H; Hansmann ML; Lennert K; Brandtzaeg P; Gatter KC; Mason DY
Am J Clin Pathol; 1986 Sep; 86(3):292-7. PubMed ID: 3529924
[TBL] [Abstract][Full Text] [Related]
30. Cytohistologic and immunohistochemical findings in Hodgkin's disease, mixed cellularity type, with a high content of epithelioid cells.
Patsouris E; Noël H; Lennert K
Am J Surg Pathol; 1989 Dec; 13(12):1014-22. PubMed ID: 2688442
[TBL] [Abstract][Full Text] [Related]
31. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies.
Abele MC; Valente G; Kerim S; Navone R; Onesti P; Chiusa L; Resegotti L; Palestro G
Haematologica; 1997; 82(3):281-5. PubMed ID: 9234572
[TBL] [Abstract][Full Text] [Related]
32. Extracellular deposition of eosinophil granule major basic protein in lymph nodes of patients with Hodgkin's disease.
Butterfield JH; Kephart GM; Banks PM; Gleich GJ
Blood; 1986 Dec; 68(6):1250-6. PubMed ID: 3535925
[TBL] [Abstract][Full Text] [Related]
33. Immunological markers of peripheral blood and lymph node lymphocytes in Hodgkin's disease.
González M; Hernández F; San Miguel JF; Moraleda JM; Caballero MD; López Borrasca A
Neoplasma; 1985; 32(2):191-8. PubMed ID: 4000308
[TBL] [Abstract][Full Text] [Related]
34. Infiltration of eosinophils in Hodgkin's disease involved lymph nodes predicts prognosis.
Enblad G; Sundstrom C; Glimelius B
Hematol Oncol; 1993; 11(4):187-93. PubMed ID: 8144133
[TBL] [Abstract][Full Text] [Related]
35. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
Gonzalez CL; Medeiros LJ; Jaffe ES
Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
[TBL] [Abstract][Full Text] [Related]
36. Immunopathology of Hodgkin's disease. Characterization of Reed-Sternberg cells with monoclonal antibodies.
Strauchen JA; Dimitriu-Bona A
Am J Pathol; 1986 May; 123(2):293-300. PubMed ID: 3085509
[TBL] [Abstract][Full Text] [Related]
37. Distribution of T-lymphocyte subsets in Hodgkin's disease characterized by monoclonal antibodies.
Dorreen MS; Habeshaw JA; Wrigley PF; Lister TA
Br J Cancer; 1982 Apr; 45(4):491-9. PubMed ID: 6978728
[TBL] [Abstract][Full Text] [Related]
38. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
Pinkus GS; Thomas P; Said JW
Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
[TBL] [Abstract][Full Text] [Related]
39. Nodular sclerosing, mixed cellularity and lymphocyte-depleted variants of Hodgkin's disease are probable dendritic cell malignancies.
Kennedy IC; Hart DN; Colls BM; Nimmo JC; Willis DA; Angus HB
Clin Exp Immunol; 1989 Jun; 76(3):324-31. PubMed ID: 2787713
[TBL] [Abstract][Full Text] [Related]
40. The immunophenotype of Reed-Sternberg cells. A study of 50 cases of Hodgkin's disease using fixed frozen tissues.
Agnarsson BA; Kadin ME
Cancer; 1989 Jun; 63(11):2083-7. PubMed ID: 2566368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
